Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

The global Biopharmaceutical and Vaccine Production market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccine Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccine Production.

Report Scope

The Biopharmaceutical and Vaccine Production market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical and Vaccine Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical and Vaccine Production companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biopharmaceutical and Vaccine Production Market Report

Report Metric	Details
Report Name	Biopharmaceutical and Vaccine Production Market
CAGR	5%
Segment by Type	Biopharmaceutical Vaccine Production
Segment by Application	Pharmaceutical Biotechnology Academic and Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Pfizer, Sanofi, Roche, Abbott, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson, GlaxoSmithKline, Merck, Lonza, FUJIFILM Diosynth Biotechnologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical and Vaccine Production companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceutical and Vaccine Production Market report?

Ans: The main players in the Biopharmaceutical and Vaccine Production Market are Novartis, Pfizer, Sanofi, Roche, Abbott, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson, GlaxoSmithKline, Merck, Lonza, FUJIFILM Diosynth Biotechnologies

What are the Application segmentation covered in the Biopharmaceutical and Vaccine Production Market report?

Ans: The Applications covered in the Biopharmaceutical and Vaccine Production Market report are Pharmaceutical, Biotechnology, Academic and Research Institutes, Others

What are the Type segmentation covered in the Biopharmaceutical and Vaccine Production Market report?

Ans: The Types covered in the Biopharmaceutical and Vaccine Production Market report are Biopharmaceutical, Vaccine Production

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Biopharmaceutical

1.2.3 Vaccine Production

1.3 Market by Application

1.3.1 Global Biopharmaceutical and Vaccine Production Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical

1.3.3 Biotechnology

1.3.4 Academic and Research Institutes

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical and Vaccine Production Market Perspective (2019-2030)

2.2 Biopharmaceutical and Vaccine Production Growth Trends by Region

2.2.1 Global Biopharmaceutical and Vaccine Production Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biopharmaceutical and Vaccine Production Historic Market Size by Region (2019-2024)

2.2.3 Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2025-2030)

2.3 Biopharmaceutical and Vaccine Production Market Dynamics

2.3.1 Biopharmaceutical and Vaccine Production Industry Trends

2.3.2 Biopharmaceutical and Vaccine Production Market Drivers

2.3.3 Biopharmaceutical and Vaccine Production Market Challenges

2.3.4 Biopharmaceutical and Vaccine Production Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue

3.1.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue (2019-2024)

3.1.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Players (2019-2024)

3.2 Global Biopharmaceutical and Vaccine Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceutical and Vaccine Production Revenue

3.4 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio

3.4.1 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccine Production Revenue in 2023

3.5 Biopharmaceutical and Vaccine Production Key Players Head office and Area Served

3.6 Key Players Biopharmaceutical and Vaccine Production Product Solution and Service

3.7 Date of Enter into Biopharmaceutical and Vaccine Production Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical and Vaccine Production Breakdown Data by Type

4.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Type (2019-2024)

4.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2025-2030)

5 Biopharmaceutical and Vaccine Production Breakdown Data by Application

5.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Application (2019-2024)

5.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biopharmaceutical and Vaccine Production Market Size (2019-2030)

6.2 North America Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024)

6.4 North America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical and Vaccine Production Market Size (2019-2030)

7.2 Europe Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024)

7.4 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size (2019-2030)

8.2 Asia-Pacific Biopharmaceutical and Vaccine Production Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2019-2024)

8.4 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical and Vaccine Production Market Size (2019-2030)

9.2 Latin America Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024)

9.4 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size (2019-2030)

10.2 Middle East & Africa Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024)

10.4 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Biopharmaceutical and Vaccine Production Introduction

11.1.4 Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Biopharmaceutical and Vaccine Production Introduction

11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.2.5 Pfizer Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Detail

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Biopharmaceutical and Vaccine Production Introduction

11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.3.5 Sanofi Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Biopharmaceutical and Vaccine Production Introduction

11.4.4 Roche Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.4.5 Roche Recent Development

11.5 Abbott

11.5.1 Abbott Company Detail

11.5.2 Abbott Business Overview

11.5.3 Abbott Biopharmaceutical and Vaccine Production Introduction

11.5.4 Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.5.5 Abbott Recent Development

11.6 Regeneron Pharmaceuticals

11.6.1 Regeneron Pharmaceuticals Company Detail

11.6.2 Regeneron Pharmaceuticals Business Overview

11.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction

11.6.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.6.5 Regeneron Pharmaceuticals Recent Development

11.7 Alexion Pharmaceuticals

11.7.1 Alexion Pharmaceuticals Company Detail

11.7.2 Alexion Pharmaceuticals Business Overview

11.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction

11.7.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.7.5 Alexion Pharmaceuticals Recent Development

11.8 Johnson and Johnson

11.8.1 Johnson and Johnson Company Detail

11.8.2 Johnson and Johnson Business Overview

11.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Introduction

11.8.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.8.5 Johnson and Johnson Recent Development

11.9 GlaxoSmithKline

11.9.1 GlaxoSmithKline Company Detail

11.9.2 GlaxoSmithKline Business Overview

11.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Introduction

11.9.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.9.5 GlaxoSmithKline Recent Development

11.10 Merck

11.10.1 Merck Company Detail

11.10.2 Merck Business Overview

11.10.3 Merck Biopharmaceutical and Vaccine Production Introduction

11.10.4 Merck Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.10.5 Merck Recent Development

11.11 Lonza

11.11.1 Lonza Company Detail

11.11.2 Lonza Business Overview

11.11.3 Lonza Biopharmaceutical and Vaccine Production Introduction

11.11.4 Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.11.5 Lonza Recent Development

11.12 FUJIFILM Diosynth Biotechnologies

11.12.1 FUJIFILM Diosynth Biotechnologies Company Detail

11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Introduction

11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)

11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Regeneron Pharmaceuticals

Alexion Pharmaceuticals

FUJIFILM Diosynth Biotechnologies

List of Tables

Table 1. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Biopharmaceutical

Table 3. Key Players of Vaccine Production

Table 4. Global Biopharmaceutical and Vaccine Production Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Biopharmaceutical and Vaccine Production Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Biopharmaceutical and Vaccine Production Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Biopharmaceutical and Vaccine Production Market Share by Region (2019-2024)

Table 8. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Biopharmaceutical and Vaccine Production Market Share by Region (2025-2030)

Table 10. Biopharmaceutical and Vaccine Production Market Trends

Table 11. Biopharmaceutical and Vaccine Production Market Drivers

Table 12. Biopharmaceutical and Vaccine Production Market Challenges

Table 13. Biopharmaceutical and Vaccine Production Market Restraints

Table 14. Global Biopharmaceutical and Vaccine Production Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Biopharmaceutical and Vaccine Production Market Share by Players (2019-2024)

Table 16. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2023)

Table 17. Ranking of Global Top Biopharmaceutical and Vaccine Production Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccine Production Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Biopharmaceutical and Vaccine Production Product Solution and Service

Table 21. Date of Enter into Biopharmaceutical and Vaccine Production Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2019-2024)

Table 25. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2025-2030)

Table 27. Global Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2019-2024)

Table 29. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2025-2030)

Table 31. North America Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030) & (US$ Million)

Table 46. Novartis Company Detail

Table 47. Novartis Business Overview

Table 48. Novartis Biopharmaceutical and Vaccine Production Product

Table 49. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 50. Novartis Recent Development

Table 51. Pfizer Company Detail

Table 52. Pfizer Business Overview

Table 53. Pfizer Biopharmaceutical and Vaccine Production Product

Table 54. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Sanofi Company Detail

Table 57. Sanofi Business Overview

Table 58. Sanofi Biopharmaceutical and Vaccine Production Product

Table 59. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 60. Sanofi Recent Development

Table 61. Roche Company Detail

Table 62. Roche Business Overview

Table 63. Roche Biopharmaceutical and Vaccine Production Product

Table 64. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 65. Roche Recent Development

Table 66. Abbott Company Detail

Table 67. Abbott Business Overview

Table 68. Abbott Biopharmaceutical and Vaccine Production Product

Table 69. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 70. Abbott Recent Development

Table 71. Regeneron Pharmaceuticals Company Detail

Table 72. Regeneron Pharmaceuticals Business Overview

Table 73. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product

Table 74. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 75. Regeneron Pharmaceuticals Recent Development

Table 76. Alexion Pharmaceuticals Company Detail

Table 77. Alexion Pharmaceuticals Business Overview

Table 78. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product

Table 79. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 80. Alexion Pharmaceuticals Recent Development

Table 81. Johnson and Johnson Company Detail

Table 82. Johnson and Johnson Business Overview

Table 83. Johnson and Johnson Biopharmaceutical and Vaccine Production Product

Table 84. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 85. Johnson and Johnson Recent Development

Table 86. GlaxoSmithKline Company Detail

Table 87. GlaxoSmithKline Business Overview

Table 88. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product

Table 89. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 90. GlaxoSmithKline Recent Development

Table 91. Merck Company Detail

Table 92. Merck Business Overview

Table 93. Merck Biopharmaceutical and Vaccine Production Product

Table 94. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 95. Merck Recent Development

Table 96. Lonza Company Detail

Table 97. Lonza Business Overview

Table 98. Lonza Biopharmaceutical and Vaccine Production Product

Table 99. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 100. Lonza Recent Development

Table 101. FUJIFILM Diosynth Biotechnologies Company Detail

Table 102. FUJIFILM Diosynth Biotechnologies Business Overview

Table 103. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product

Table 104. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)

Table 105. FUJIFILM Diosynth Biotechnologies Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceutical and Vaccine Production Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Biopharmaceutical and Vaccine Production Market Share by Type: 2023 VS 2030

Figure 3. Biopharmaceutical Features

Figure 4. Vaccine Production Features

Figure 5. Global Biopharmaceutical and Vaccine Production Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Biopharmaceutical and Vaccine Production Market Share by Application: 2023 VS 2030

Figure 7. Pharmaceutical Case Studies

Figure 8. Biotechnology Case Studies

Figure 9. Academic and Research Institutes Case Studies

Figure 10. Others Case Studies

Figure 11. Biopharmaceutical and Vaccine Production Report Years Considered

Figure 12. Global Biopharmaceutical and Vaccine Production Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Biopharmaceutical and Vaccine Production Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Biopharmaceutical and Vaccine Production Market Share by Region: 2023 VS 2030

Figure 15. Global Biopharmaceutical and Vaccine Production Market Share by Players in 2023

Figure 16. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2023

Figure 18. North America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Biopharmaceutical and Vaccine Production Market Share by Country (2019-2030)

Figure 20. United States Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Biopharmaceutical and Vaccine Production Market Share by Country (2019-2030)

Figure 24. Germany Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Biopharmaceutical and Vaccine Production Market Share by Region (2019-2030)

Figure 32. China Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Biopharmaceutical and Vaccine Production Market Share by Country (2019-2030)

Figure 40. Mexico Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Biopharmaceutical and Vaccine Production Market Share by Country (2019-2030)

Figure 44. Turkey Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 47. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 48. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 49. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 50. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 51. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 52. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 53. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 55. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 56. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 57. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions